Primecap Management’s Allogene Therapeutics ALLO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.4M	Buy	8,379,840 +240,000	+3%	+$481K	0.02%	231
2025 Q4	$11.2M	Buy	8,139,840 +1,060,532	+15%	+$1.4M	0.01%	250
2025 Q3	$8.78M	Buy	7,079,308 +1,360,168	+24%	+$1.62M	0.01%	263
2025 Q2	$6.46M	Buy	5,719,140 +787,300	+16%	+$1.05M	0.01%	277
2025 Q1	$7.2M	Buy	4,931,840 +4,500	+0.1%	+$8.48K	0.01%	267
2024 Q4	$10.5M	Sell	4,927,340 -740,920	-13%	-$1.83M	0.01%	254
2024 Q3	$15.9M	Sell	5,668,260 -1,966	-0%	-$5.24K	0.01%	247
2024 Q2	$13.2M	Buy	5,670,226 +221,840	+4%	+$654K	0.01%	249
2024 Q1	$24.4M	Buy	5,448,386 +166,500	+3%	+$695K	0.02%	222
2023 Q4	$17M	Sell	5,281,886 -2,500	-0%	-$7.09K	0.01%	237
2023 Q3	$16.8M	Sell	5,284,386 -352,300	-6%	-$1.54M	0.01%	238
2023 Q2	$28M	Sell	5,636,686 -132,300	-2%	-$716K	0.02%	216
2023 Q1	$28.5M	Buy	5,768,986 +825,070	+17%	+$5.29M	0.02%	208
2022 Q4	$31.1M	Buy	4,943,916 +51,050	+1%	+$473K	0.03%	192
2022 Q3	$52.8M	Buy	4,892,866 +9,900	+0.2%	+$135K	0.05%	169
2022 Q2	$55.7M	Sell	4,882,966 -23,300	-0.5%	-$207K	0.05%	171
2022 Q1	$44.7M	Buy	4,906,266 +244,451	+5%	+$2.55M	0.03%	198
2021 Q4	$69.6M	Buy	4,661,815 +1,057,515	+29%	+$18.7M	0.05%	175
2021 Q3	$92.6M	Buy	3,604,300 +27,270	+0.8%	+$647K	0.07%	158
2021 Q2	$93.3M	Buy	3,577,030 +2,271,630	+174%	+$64.8M	0.06%	157
2021 Q1	$46.1M	Buy	1,305,400 +67,000	+5%	+$2.26M	0.03%	198
2020 Q4	$31.3M	Buy	+1,238,400	New	+$40.4M	0.02%	210